
Rafferty Asset Management’s Sana Biotechnology SANA Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-195,135
| Closed | -$328K | – | 1101 |
|
2025
Q1 | $328K | Sell |
195,135
-118,716
| -38% | -$199K | ﹤0.01% | 938 |
|
2024
Q4 | $512K | Sell |
313,851
-10,680
| -3% | -$17.4K | ﹤0.01% | 907 |
|
2024
Q3 | $1.35M | Sell |
324,531
-15,899
| -5% | -$66.1K | ﹤0.01% | 729 |
|
2024
Q2 | $1.86M | Sell |
340,430
-155,502
| -31% | -$849K | 0.01% | 667 |
|
2024
Q1 | $4.96M | Buy |
495,932
+58,318
| +13% | +$583K | 0.02% | 477 |
|
2023
Q4 | $1.79M | Buy |
437,614
+112,732
| +35% | +$460K | 0.01% | 699 |
|
2023
Q3 | $1.26M | Sell |
324,882
-10,901
| -3% | -$42.2K | 0.01% | 731 |
|
2023
Q2 | $2M | Sell |
335,783
-72,462
| -18% | -$432K | 0.01% | 643 |
|
2023
Q1 | $1.33M | Sell |
408,245
-103,480
| -20% | -$338K | 0.01% | 723 |
|
2022
Q4 | $2.02M | Buy |
511,725
+82,559
| +19% | +$326K | 0.02% | 574 |
|
2022
Q3 | $2.58M | Buy |
429,166
+58,859
| +16% | +$353K | 0.03% | 455 |
|
2022
Q2 | $2.38M | Sell |
370,307
-114,625
| -24% | -$737K | 0.02% | 429 |
|
2022
Q1 | $4.01M | Buy |
484,932
+287,779
| +146% | +$2.38M | 0.02% | 430 |
|
2021
Q4 | $3.05M | Buy |
197,153
+124,729
| +172% | +$1.93M | 0.02% | 535 |
|
2021
Q3 | $1.63M | Sell |
72,424
-14,876
| -17% | -$335K | 0.01% | 688 |
|
2021
Q2 | $1.72M | Buy |
+87,300
| New | +$1.72M | 0.01% | 732 |
|